132 related articles for article (PubMed ID: 3010623)
21. [Studies for clinical application of ovine corticotropin-releasing factor].
Kubo M
Hokkaido Igaku Zasshi; 1985 Mar; 60(2):282-98. PubMed ID: 2987091
[TBL] [Abstract][Full Text] [Related]
22. Immunoreactive corticotropin-releasing factor in rat plasma.
Sumitomo T; Suda T; Tomori N; Yajima F; Nakagami Y; Ushiyama T; Demura H; Shizume K
Endocrinology; 1987 Apr; 120(4):1391-6. PubMed ID: 3030699
[TBL] [Abstract][Full Text] [Related]
23. An ACTH-secreting bronchial carcinoid: presence of corticotropin-releasing hormone, neuropeptide Y and endothelin-1 in the tumor tissue.
Murakami O; Takahashi K; Sone M; Totsune K; Ohneda M; Itoi K; Yoshinaga K; Mouri T
Acta Endocrinol (Copenh); 1993 Feb; 128(2):192-6. PubMed ID: 8383906
[TBL] [Abstract][Full Text] [Related]
24. Phosphorylated forms of adrenocorticotropin and corticotropin-like intermediary lobe peptide in human tumors.
Massias JF; Hardouin S; Vieau D; Lenne F; Bertagna X
Eur J Endocrinol; 1994 Oct; 131(4):341-6. PubMed ID: 7921221
[TBL] [Abstract][Full Text] [Related]
25. Immunoreactive corticotropin-releasing factor in human plasma.
Suda T; Tomori N; Yajima F; Sumitomo T; Nakagami Y; Ushiyama T; Demura H; Shizume K
J Clin Invest; 1985 Nov; 76(5):2026-9. PubMed ID: 2997301
[TBL] [Abstract][Full Text] [Related]
26. Corticotropin releasing factor: a new tool for the differential diagnosis of Cushing's syndrome.
Müller OA; Stalla GK; von Werder K
J Clin Endocrinol Metab; 1983 Jul; 57(1):227-9. PubMed ID: 6304135
[TBL] [Abstract][Full Text] [Related]
27. Characterisation of Met-enkephalin(Arg6,Phe7) immunoreactivity in human adrenal and human phaeochromocytoma.
Boarder MR; McArdle W
Regul Pept; 1984 Oct; 9(3):187-97. PubMed ID: 6528059
[TBL] [Abstract][Full Text] [Related]
28. Pituitary and adrenal responses to ovine corticotropin releasing factor and vasopressin injected into young and adult guinea-pigs.
Pradier P; Tournaire C; Dalle M
J Dev Physiol; 1990 Sep; 14(3):163-9. PubMed ID: 1966108
[TBL] [Abstract][Full Text] [Related]
29. Direct secretagogue effect of corticotropin-releasing factor on the rat adrenal cortex: the involvement of the zona medullaris.
Andreis PG; Neri G; Mazzocchi G; Musajo F; Nussdorfer GG
Endocrinology; 1992 Jul; 131(1):69-72. PubMed ID: 1319330
[TBL] [Abstract][Full Text] [Related]
30. Circulating adrenomedullin is increased in patients with corticotropin-dependent Cushing's syndrome due to pituitary adenoma.
Letizia C; Di Iorio R; De Toma G; Marinoni E; Cerci S; Celi M; Subioli S; D'Erasmo E
Metabolism; 2000 Jun; 49(6):760-3. PubMed ID: 10877203
[TBL] [Abstract][Full Text] [Related]
31. Effects of corticotropin-releasing factor and other materials on adrenocorticotropin secretion from pituitary glands of patients with Cushing's disease in vitro.
Suda T; Tomori N; Tozawa F; Demura H; Shizume K
J Clin Endocrinol Metab; 1984 Nov; 59(5):840-5. PubMed ID: 6148354
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous measurement of beta-endorphin, lipotrophins and met-enkephalin in phaeochromocytomas.
Bertagna X; Pique L; Ochoa C; Luton JP; Bricaire H; Serin D; Girard F; Plouin PF; Corvol P; Cesselin F; Hamon M
Acta Endocrinol (Copenh); 1982 Sep; 101(1):72-7. PubMed ID: 6289592
[TBL] [Abstract][Full Text] [Related]
33. Urocortin 1, urocortin 3/stresscopin, and corticotropin-releasing factor receptors in human adrenal and its disorders.
Fukuda T; Takahashi K; Suzuki T; Saruta M; Watanabe M; Nakata T; Sasano H
J Clin Endocrinol Metab; 2005 Aug; 90(8):4671-8. PubMed ID: 15914529
[TBL] [Abstract][Full Text] [Related]
34. Ectopic secretion of corticotropin-releasing factor as a cause of Cushing's syndrome. A clinical, morphologic, and biochemical study.
Carey RM; Varma SK; Drake CR; Thorner MO; Kovacs K; Rivier J; Vale W
N Engl J Med; 1984 Jul; 311(1):13-20. PubMed ID: 6328303
[TBL] [Abstract][Full Text] [Related]
35. A study of hypothalamic-pituitary-adrenal suppression following curative surgery for Cushing's syndrome due to adrenal adenoma.
Gordon D; Semple CG; Beastall GH; Thomson JA
Acta Endocrinol (Copenh); 1987 Feb; 114(2):166-70. PubMed ID: 3030034
[TBL] [Abstract][Full Text] [Related]
36. Phaeochromocytoma and ACTH-dependent cushing's syndrome: tumour crf secretion can mimic pituitary cushing's disease.
Lois KB; Santhakumar A; Vaikkakara S; Mathew S; Long A; Johnson SJ; Peaston R; Neely RDG; Richardson DL; Graham J; Lennard TWJ; Bliss R; Miller M; Ball SG; Pearce SHS; Woods DR; Quinton R
Clin Endocrinol (Oxf); 2016 Feb; 84(2):177-184. PubMed ID: 26433209
[TBL] [Abstract][Full Text] [Related]
37. Effect of ovine corticotrophin releasing factor, bromocriptine, and dopamine on release of ACTH and beta-endorphin in a patient with Cushing's disease.
Nakashima H; Hirata Y; Uchihashi M; Tomita M; Fujita T
Acta Endocrinol (Copenh); 1985 May; 109(1):7-12. PubMed ID: 2988259
[TBL] [Abstract][Full Text] [Related]
38. Studies on ectopic ACTH-producing tumours. IV. CRF-like activity in tumour tissue.
Yamamoto H; Hirata Y; Matsukura S; Imura H; Nakamura M; Tanaka A
Acta Endocrinol (Copenh); 1976 May; 82(1):183-92. PubMed ID: 178136
[No Abstract] [Full Text] [Related]
39. Effect of the long-term administration of corticotropin-releasing factor on the pituitary-adrenal and pituitary-gonadal axis in the male rat.
Rivier C; Vale W
J Clin Invest; 1985 Feb; 75(2):689-94. PubMed ID: 2982917
[TBL] [Abstract][Full Text] [Related]
40. Pituitary-adrenal responses to corticotropin-releasing factor in late onset 21-hydroxylase deficiency.
Carmina E; Lobo RA
Fertil Steril; 1990 Jul; 54(1):79-83. PubMed ID: 2162789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
